A Clínic-IDIBAPS study discovers that nanoparticles with DNA enhance the effect of immunotherapy against cancer
A study co-led by Sònia Guedan, head of the IDIBAPS Cellular immunotherapies for cancer group, has s...
Publisher
Spain
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
A study co-led by Sònia Guedan, head of the IDIBAPS Cellular immunotherapies for cancer group, has s...
Source route
Continue on clinicbarcelona.org
Leave the platform to read the original full article on the publisher site.
Source: Hospital Clínic de Barcelona
Scope: Research
Related coverage
More related coverage
KSHB: Stage 4 Colon Cancer Patient Encourages Colonoscopies As Doctors See Rise in Cases in Younger Adults
Jimmie Kinder was diagnosed with stage 4 colon cancer at age 50. Now, he is encouraging everyone to...
How AML Leukemia Cells Use a “Sugar Coat” to Hide from the Immune System, CRISPR Screen Finds
Dana-Farber Cancer Institute researchers, in collaboration with the Broad Institute and Mass General...
A simple model makes it possible to predict which patients experiencing a first psychotic episode will recover during the first year
A multicentre team, led by Sergi Mas, lecturer in the Pharmacology Unit of the Department of Clinica...
virtual hospital pilot program brings care home to more victorians
Victoria’s landmark Virtual Hospital project – led through a partnership between the Royal Melbourne...